| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
119,430 |
103,890 |
$21.79M |
| 0250 |
|
42,441 |
22,310 |
$6.25M |
| 0301 |
|
5,828 |
5,335 |
$1.75M |
| 0121 |
|
353 |
336 |
$1.44M |
| 70450 |
Computed tomography, head or brain; without contrast material |
8,452 |
8,179 |
$1.12M |
| Z7502 |
|
28,171 |
27,838 |
$1.07M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,577 |
7,973 |
$961K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,974 |
3,859 |
$871K |
| A9150 |
Non-prescription drugs |
5,120 |
2,695 |
$829K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
4,965 |
4,775 |
$814K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,891 |
8,156 |
$795K |
| 0214 |
|
228 |
210 |
$793K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
6,017 |
4,896 |
$787K |
| 71045 |
Radiologic examination, chest; single view |
21,787 |
20,685 |
$660K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,359 |
4,131 |
$622K |
| 0949 |
|
18,040 |
13,822 |
$558K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
17,595 |
16,390 |
$548K |
| 59025 |
Fetal non-stress test |
12,259 |
3,268 |
$547K |
| 99199 |
Unlisted special service, procedure or report |
6,123 |
5,118 |
$546K |
| 81025 |
|
22,390 |
21,017 |
$535K |
| J3490 |
Unclassified drugs |
54,841 |
30,704 |
$520K |
| 80053 |
Comprehensive metabolic panel |
24,257 |
22,603 |
$516K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
29,591 |
27,074 |
$440K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
17,843 |
16,542 |
$438K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,997 |
2,922 |
$430K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
5,566 |
4,818 |
$419K |
| 0750 |
|
1,967 |
1,921 |
$381K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
4,682 |
4,492 |
$380K |
| 71046 |
Radiologic examination, chest; 2 views |
8,867 |
8,580 |
$373K |
| Z7500 |
|
10,843 |
7,619 |
$367K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
6,193 |
5,895 |
$366K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
7,389 |
3,851 |
$362K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17,931 |
16,199 |
$337K |
| 86850 |
|
4,189 |
4,039 |
$303K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,743 |
2,686 |
$296K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
12,408 |
11,437 |
$288K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
39,168 |
35,872 |
$267K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,565 |
3,396 |
$256K |
| 93971 |
|
1,803 |
1,750 |
$244K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,490 |
4,152 |
$242K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,070 |
1,947 |
$236K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,345 |
3,244 |
$226K |
| 99221 |
|
8,820 |
7,663 |
$219K |
| 0122 |
|
107 |
106 |
$216K |
| 0360 |
|
4,220 |
4,020 |
$211K |
| Z9725 |
|
4,643 |
4,469 |
$199K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,531 |
2,465 |
$198K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,385 |
2,233 |
$198K |
| 76801 |
|
3,365 |
2,932 |
$188K |
| 0420 |
|
2,287 |
609 |
$167K |
| 0510 |
|
5,419 |
5,069 |
$159K |
| 0720 |
|
3,591 |
2,963 |
$145K |
| 82962 |
|
5,007 |
4,248 |
$144K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,224 |
1,149 |
$139K |
| 99381 |
|
1,045 |
1,034 |
$133K |
| 36415 |
Collection of venous blood by venipuncture |
8,125 |
7,523 |
$133K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
2,873 |
2,577 |
$118K |
| 0710 |
|
4,569 |
4,394 |
$115K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
877 |
789 |
$114K |
| 73130 |
|
2,175 |
2,119 |
$113K |
| 0270 |
|
29,403 |
16,601 |
$113K |
| 81001 |
|
24,301 |
23,005 |
$111K |
| 83880 |
|
6,607 |
6,243 |
$111K |
| 73030 |
|
2,007 |
1,959 |
$110K |
| 73562 |
|
2,033 |
1,994 |
$107K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
9,003 |
8,663 |
$106K |
| 84484 |
|
14,024 |
12,788 |
$104K |
| 80076 |
|
6,656 |
6,393 |
$103K |
| 73610 |
|
2,142 |
2,081 |
$101K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,174 |
4,762 |
$101K |
| 73630 |
|
2,136 |
2,091 |
$101K |
| 76830 |
Ultrasound, transvaginal |
1,766 |
1,719 |
$99K |
| 0200 |
|
30 |
28 |
$96K |
| 80047 |
|
2,744 |
2,626 |
$92K |
| 70486 |
|
904 |
889 |
$91K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,721 |
3,629 |
$91K |
| 93970 |
|
465 |
460 |
$90K |
| 76813 |
|
1,629 |
1,322 |
$87K |
| Z1034 |
|
1,256 |
1,024 |
$87K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,718 |
3,628 |
$85K |
| 83690 |
|
14,853 |
13,991 |
$85K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
9,282 |
8,884 |
$83K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,043 |
1,960 |
$83K |
| 86803 |
|
7,376 |
7,145 |
$82K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,400 |
3,845 |
$79K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,599 |
2,432 |
$79K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
15,759 |
14,581 |
$75K |
| 0762 |
|
1,159 |
909 |
$75K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
441 |
431 |
$75K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,880 |
3,723 |
$74K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
695 |
693 |
$74K |
| Z6304 |
|
2,414 |
2,053 |
$72K |
| 81003 |
|
14,100 |
13,125 |
$72K |
| 0760 |
|
2,556 |
2,303 |
$71K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,589 |
2,316 |
$71K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,905 |
1,694 |
$69K |
| 97802 |
|
1,877 |
1,829 |
$61K |
| 0636 |
|
455 |
417 |
$61K |
| 73110 |
|
1,396 |
1,362 |
$59K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
611 |
573 |
$59K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
234 |
226 |
$59K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
383 |
378 |
$58K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
290 |
279 |
$56K |
| Z7610 |
|
11,873 |
7,083 |
$53K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
14,081 |
13,367 |
$52K |
| Z6500 |
|
269 |
269 |
$52K |
| 0370 |
|
1,617 |
1,578 |
$50K |
| 90715 |
|
1,326 |
1,289 |
$50K |
| 84702 |
|
4,271 |
3,924 |
$48K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
667 |
640 |
$48K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,468 |
5,128 |
$47K |
| 85520 |
|
5,138 |
4,989 |
$46K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,822 |
1,689 |
$46K |
| 0160 |
|
886 |
618 |
$45K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,485 |
1,411 |
$44K |
| 83605 |
|
4,413 |
4,097 |
$43K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,296 |
4,999 |
$43K |
| 96156 |
|
554 |
527 |
$40K |
| 85730 |
|
8,530 |
8,203 |
$39K |
| 87040 |
|
2,818 |
2,474 |
$39K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
11,050 |
10,262 |
$38K |
| 10060 |
|
810 |
785 |
$38K |
| 85610 |
|
10,790 |
10,245 |
$37K |
| 86900 |
|
5,270 |
5,044 |
$35K |
| Z1032 |
|
171 |
170 |
$34K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
8,037 |
7,121 |
$33K |
| 93798 |
|
986 |
190 |
$33K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
827 |
795 |
$32K |
| 73140 |
|
824 |
814 |
$32K |
| 73080 |
|
686 |
670 |
$29K |
| 86780 |
|
2,575 |
2,463 |
$29K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,520 |
2,321 |
$28K |
| 73590 |
|
739 |
719 |
$27K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
739 |
718 |
$27K |
| Z6400 |
|
919 |
898 |
$27K |
| 71250 |
|
197 |
191 |
$26K |
| 87631 |
|
439 |
418 |
$26K |
| 85027 |
|
5,486 |
5,193 |
$25K |
| 73502 |
|
467 |
454 |
$25K |
| 87077 |
|
3,160 |
3,037 |
$25K |
| 0761 |
|
977 |
787 |
$23K |
| 90714 |
|
1,358 |
1,337 |
$23K |
| 76642 |
|
613 |
605 |
$23K |
| 0171 |
Inj, epinephrine (belcher) |
67 |
67 |
$22K |
| B4160 |
Enteral formula, for pediatrics, nutritionally complete calorically dense (equal to or greater than 0.7 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit |
101 |
91 |
$22K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,143 |
3,025 |
$21K |
| 83735 |
|
4,418 |
3,910 |
$21K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,348 |
4,243 |
$21K |
| 12001 |
|
418 |
403 |
$20K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
392 |
378 |
$20K |
| 87210 |
|
2,166 |
2,094 |
$19K |
| 96376 |
|
1,681 |
1,518 |
$19K |
| 74018 |
|
306 |
297 |
$19K |
| Z6406 |
|
925 |
760 |
$19K |
| 77066 |
Tomosynthesis, mammo |
255 |
255 |
$18K |
| 12011 |
|
293 |
282 |
$18K |
| 81002 |
|
7,085 |
5,014 |
$17K |
| 90670 |
|
2,022 |
1,864 |
$17K |
| 73090 |
|
345 |
337 |
$17K |
| 0272 |
|
1,400 |
1,378 |
$16K |
| J1953 |
Injection, levetiracetam, 10 mg |
353 |
311 |
$16K |
| 88312 |
|
1,795 |
1,707 |
$16K |
| 82803 |
|
1,057 |
1,026 |
$15K |
| Z7506 |
|
119 |
117 |
$15K |
| 0424 |
|
128 |
65 |
$15K |
| 73564 |
|
260 |
256 |
$15K |
| 86901 |
|
5,272 |
5,048 |
$15K |
| Z6204 |
|
1,029 |
798 |
$15K |
| 87186 |
|
1,555 |
1,492 |
$14K |
| 73620 |
|
162 |
161 |
$13K |
| 90680 |
|
1,966 |
1,863 |
$13K |
| 76870 |
|
146 |
140 |
$12K |
| 77065 |
Tomosynthesis, mammo |
170 |
166 |
$12K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
194 |
188 |
$12K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,592 |
3,412 |
$12K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,023 |
1,004 |
$11K |
| 70496 |
|
59 |
58 |
$11K |
| J1815 |
Injection, insulin, per 5 units |
585 |
457 |
$11K |
| A4649 |
Surgical supply; miscellaneous |
2,449 |
1,541 |
$11K |
| A9270 |
Non-covered item or service |
4,797 |
2,500 |
$10K |
| 96150 |
|
441 |
434 |
$10K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,561 |
2,470 |
$10K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
506 |
485 |
$10K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
41 |
41 |
$10K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
114 |
111 |
$10K |
| 90723 |
|
1,379 |
1,314 |
$9K |
| 97804 |
|
1,159 |
1,142 |
$9K |
| J2704 |
Injection, propofol, 10 mg |
2,258 |
2,188 |
$8K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
251 |
207 |
$8K |
| 84100 |
|
2,348 |
2,090 |
$8K |
| 90648 |
|
1,263 |
1,183 |
$8K |
| 29125 |
|
334 |
327 |
$7K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,809 |
2,658 |
$7K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
571 |
541 |
$7K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,905 |
2,804 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
835 |
805 |
$7K |
| J2060 |
Injection, lorazepam, 2 mg |
2,352 |
2,144 |
$7K |
| D0150 |
Comprehensive oral evaluation - new or established patient |
114 |
114 |
$7K |
| 94726 |
|
229 |
217 |
$7K |
| 72131 |
|
48 |
48 |
$6K |
| 84145 |
|
397 |
387 |
$6K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
280 |
258 |
$6K |
| 72110 |
|
102 |
100 |
$6K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,107 |
2,012 |
$6K |
| 94729 |
|
192 |
189 |
$6K |
| 36821 |
|
50 |
50 |
$6K |
| 86762 |
|
336 |
336 |
$5K |
| 36600 |
|
224 |
209 |
$5K |
| 72170 |
|
108 |
108 |
$5K |
| 85014 |
|
2,798 |
2,680 |
$5K |
| 0721 |
|
93 |
90 |
$5K |
| 70498 |
|
59 |
58 |
$5K |
| 72100 |
|
82 |
82 |
$5K |
| 82550 |
|
904 |
858 |
$5K |
| J2785 |
Injection, regadenoson, 0.1 mg |
29 |
29 |
$5K |
| 93017 |
|
72 |
68 |
$5K |
| 90710 |
|
713 |
686 |
$5K |
| 96151 |
|
273 |
177 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
462 |
454 |
$4K |
| D0210 |
Intraoral - complete series of radiographic images |
86 |
86 |
$4K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
561 |
520 |
$4K |
| 90647 |
|
1,129 |
1,073 |
$4K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
752 |
627 |
$4K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
181 |
179 |
$4K |
| 82950 |
|
677 |
676 |
$4K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,024 |
840 |
$4K |
| 90700 |
|
1,635 |
1,534 |
$4K |
| 12002 |
|
81 |
80 |
$4K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
29 |
29 |
$4K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,627 |
1,470 |
$3K |
| 97803 |
|
169 |
134 |
$3K |
| Z6308 |
|
109 |
101 |
$3K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,003 |
979 |
$3K |
| 90713 |
|
1,042 |
974 |
$3K |
| 76770 |
|
78 |
78 |
$3K |
| 0430 |
|
56 |
42 |
$3K |
| G0378 |
Hospital observation service, per hour |
131 |
105 |
$3K |
| J7050 |
Infusion, normal saline solution, 250 cc |
823 |
816 |
$3K |
| 87400 |
|
184 |
168 |
$3K |
| 90750 |
|
41 |
40 |
$2K |
| 85379 |
|
382 |
369 |
$2K |
| 81000 |
|
836 |
558 |
$2K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
47 |
44 |
$2K |
| 73600 |
|
26 |
25 |
$2K |
| 90734 |
|
100 |
94 |
$2K |
| 84439 |
|
206 |
201 |
$2K |
| 80061 |
Lipid panel |
261 |
247 |
$2K |
| 0258 |
|
199 |
194 |
$2K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
169 |
53 |
$2K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
110 |
101 |
$2K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
40 |
39 |
$2K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
826 |
772 |
$2K |
| 92551 |
|
1,078 |
1,028 |
$2K |
| 70360 |
|
14 |
12 |
$2K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
229 |
222 |
$2K |
| 86140 |
|
381 |
367 |
$2K |
| 0305 |
|
1,068 |
999 |
$2K |
| Z6300 |
|
66 |
66 |
$2K |
| Z6200 |
|
66 |
66 |
$2K |
| 0412 |
|
116 |
108 |
$2K |
| 85007 |
|
908 |
864 |
$2K |
| Z6402 |
|
65 |
65 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
73 |
72 |
$2K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
120 |
120 |
$1K |
| 90649 |
|
50 |
42 |
$1K |
| 90633 |
|
964 |
889 |
$1K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
41 |
36 |
$1K |
| 0300 |
|
1,102 |
998 |
$1K |
| 85380 |
|
303 |
287 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
460 |
444 |
$1K |
| 82105 |
|
232 |
225 |
$1K |
| 0460 |
|
75 |
74 |
$1K |
| 87522 |
Neg quan hep c or qual rna |
113 |
109 |
$1K |
| J1630 |
Injection, haloperidol, up to 5 mg |
237 |
221 |
$1K |
| Z7512 |
|
43 |
43 |
$1K |
| 82140 |
|
87 |
86 |
$1K |
| 90658 |
|
151 |
146 |
$1K |
| 71020 |
|
40 |
19 |
$948.83 |
| 90686 |
|
74 |
73 |
$901.30 |
| 73552 |
|
24 |
24 |
$879.97 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
128 |
115 |
$868.51 |
| J1644 |
Injection, heparin sodium, per 1000 units |
237 |
142 |
$830.29 |
| G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes |
15 |
15 |
$804.33 |
| 0324 |
|
503 |
480 |
$788.64 |
| 0002A |
|
21 |
21 |
$778.39 |
| 82010 |
|
128 |
121 |
$766.11 |
| K0001 |
Standard wheelchair |
13 |
13 |
$764.10 |
| 94010 |
|
28 |
27 |
$750.71 |
| 59425 |
|
74 |
51 |
$743.88 |
| 87340 |
|
357 |
352 |
$719.75 |
| 87081 |
|
94 |
94 |
$715.34 |
| 71010 |
|
54 |
22 |
$701.13 |
| 0031A |
|
17 |
17 |
$680.00 |
| T4541 |
Incontinence product, disposable underpad, large, each |
26 |
25 |
$667.00 |
| 99401 |
|
170 |
154 |
$646.78 |
| 99070 |
|
445 |
261 |
$625.83 |
| 80185 |
|
28 |
26 |
$607.69 |
| 29515 |
|
26 |
25 |
$593.07 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
46 |
14 |
$576.20 |
| J3486 |
Injection, ziprasidone mesylate, 10 mg |
20 |
17 |
$574.70 |
| 27502 |
|
36 |
30 |
$558.14 |
| 88142 |
|
153 |
153 |
$540.92 |
| 73060 |
|
27 |
27 |
$530.63 |
| 87147 |
|
132 |
131 |
$479.85 |
| 73120 |
|
12 |
12 |
$468.34 |
| E1390 |
Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate |
14 |
14 |
$446.01 |
| 90716 |
|
170 |
147 |
$442.60 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
25 |
24 |
$421.78 |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
86 |
64 |
$415.59 |
| 0001A |
|
25 |
25 |
$398.10 |
| 84481 |
|
57 |
57 |
$378.91 |
| 82247 |
|
74 |
56 |
$357.81 |
| J1940 |
Injection, furosemide, up to 20 mg |
83 |
66 |
$351.95 |
| 90707 |
|
164 |
140 |
$322.37 |
| 99173 |
|
786 |
763 |
$316.89 |
| S0265 |
Genetic counseling, under physician supervision, each 15 minutes |
28 |
28 |
$315.94 |
| Z6410 |
|
13 |
13 |
$313.69 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
16 |
15 |
$305.10 |
| 87070 |
|
27 |
26 |
$282.57 |
| E0431 |
Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing |
12 |
12 |
$282.05 |
| 0307 |
|
421 |
408 |
$281.03 |
| 86580 |
|
40 |
37 |
$279.78 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
117 |
112 |
$279.15 |
| 88304 |
|
168 |
162 |
$274.05 |
| 94060 |
|
14 |
13 |
$273.39 |
| 0730 |
|
401 |
379 |
$264.83 |
| 0302 |
|
416 |
393 |
$250.20 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
30 |
14 |
$248.45 |
| A9698 |
Non-radioactive contrast imaging material, not otherwise classified, per study |
74 |
69 |
$223.74 |
| 85652 |
|
101 |
96 |
$213.29 |
| Z6408 |
|
12 |
12 |
$193.44 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
112 |
109 |
$188.85 |
| 0306 |
|
679 |
648 |
$187.00 |
| V2632 |
Posterior chamber intraocular lens |
24 |
24 |
$184.92 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
48 |
43 |
$176.49 |
| 85018 |
|
177 |
137 |
$161.86 |
| Z6206 |
|
12 |
12 |
$145.08 |
| S0028 |
Injection, famotidine, 20 mg |
287 |
279 |
$127.17 |
| 96040 |
|
27 |
26 |
$120.00 |
| 88342 |
|
17 |
16 |
$118.77 |
| Z6412 |
|
12 |
12 |
$96.72 |
| Z6306 |
|
12 |
12 |
$96.72 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
27 |
25 |
$95.63 |
| D0230 |
Intraoral - periapical each additional radiographic image |
23 |
12 |
$93.15 |
| 86592 |
|
15 |
15 |
$75.36 |
| V5008 |
Hearing screening |
30 |
28 |
$73.03 |
| 84550 |
|
31 |
26 |
$70.66 |
| 90685 |
|
19 |
12 |
$63.00 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
24 |
12 |
$60.18 |
| 82248 |
|
102 |
75 |
$51.50 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
19 |
13 |
$44.10 |
| 82728 |
|
27 |
27 |
$42.24 |
| 0402 |
|
85 |
85 |
$40.76 |
| 83540 |
|
14 |
14 |
$4.58 |
| 99072 |
|
16 |
12 |
$2.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
66 |
63 |
$0.00 |
| 99382 |
|
112 |
107 |
$0.00 |
| 0320 |
|
72 |
70 |
$0.00 |
| 0361 |
|
27 |
27 |
$0.00 |
| 98968 |
|
14 |
13 |
$0.00 |
| 0351 |
|
39 |
39 |
$0.00 |
| 0489 |
|
76 |
76 |
$0.00 |
| E0601 |
Continuous positive airway pressure (cpap) device |
12 |
12 |
$0.00 |
| 0682 |
|
12 |
12 |
$0.00 |
| 99172 |
|
28 |
28 |
$0.00 |
| D0120 |
Periodic oral evaluation - established patient |
78 |
78 |
$0.00 |
| 0352 |
|
62 |
61 |
$0.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
36 |
36 |
$0.00 |
| 0410 |
|
31 |
31 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
78 |
78 |
$0.00 |
| E0570 |
Nebulizer, with compressor |
12 |
12 |
$0.00 |
| 0310 |
|
26 |
25 |
$0.00 |
| 99383 |
|
12 |
12 |
$0.00 |